# US 2004/0082779 A1 · Melanocortin-4 receptor binding compounds and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0082779 A1
- Document ID: US20040082779A1
- Status: Published application
- Kind: A1
- Application number: 10/462,436
- Filed: 2003-06-16
- Published: 2004-04-29
- Earliest claimed: 1999-08-04
- Assignees: Millennium Pharmaceuticals, Inc.
- Inventors: Tricia J. Vos; Michael E. Solomon; Christopher F. Claiborne; Martin P. Maguire; Mingshi Dai; Michael Patane; Thomas H. Marsilje
- Web page: https://patentgrep.com/patent/US20040082779A1

## CPC

- C07D 471/04: Ortho-condensed systems
- A61K 31/4164: 1,3-Diazoles
- A61K 31/4174: Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/4184: condensed with carbocyclic rings, e.g. benzimidazoles
- A61K 31/505: Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 31/18: for HIV
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07C 211/27: having amino groups linked to the six-membered aromatic ring by saturated carbon chains
- C07C 211/29: the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
- C07C 211/30: the six-membered aromatic ring being part of a condensed ring system formed by two rings
- C07C 237/38: having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C07C 257/18: having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
- C07C 271/20: to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
- C07C 275/26: having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07D 233/06: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D 233/10: with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring nitrogen atoms
- C07D 233/18: Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D 233/20: with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D 233/22: Radicals substituted by oxygen atoms
- C07D 233/26: Radicals substituted by carbon atoms having three bonds to hetero atoms
- C07D 233/30: Oxygen or sulfur atoms
- C07D 233/42: Sulfur atoms
- C07D 233/48: with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
- C07D 235/12: Radicals substituted by oxygen atoms
- C07D 235/18: with aryl radicals directly attached in position 2
- C07D 239/06: having one double bond between ring members or between a ring member and a non-ring member
- C07D 295/073: with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 295/088: to an acyclic saturated chain
- C07D 295/13: to an acyclic saturated chain
- C07D 295/135: with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 403/14: containing three or more hetero rings
- C07D 405/10: linked by a carbon chain containing aromatic rings
- C07D 405/14: containing three or more hetero rings
- C07D 409/04: directly linked by a ring-member-to-ring-member bond
- C07D 409/10: linked by a carbon chain containing aromatic rings
- C07D 409/12: linked by a chain containing hetero atoms as chain links
- C07D 487/04: Ortho-condensed systems
- C07D 513/04: Ortho-condensed systems
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

Provided are MC4-R binding compounds of the formula XVII: 1 wherein L2 is a linker group, and P1, P2, P3, P4, Z1, Z2, Z3, Z4, Z5, t, s, and R are as described in the specification. Methods of using the compounds to treat MC4-R associated disorders, such as disorders associated with weight loss, are also provided.

## Claims

### Claim 1

A compound of formula XVII:
818
or a pharmaceutically acceptable salt thereof, wherein:
P1, P2, P3, and P4 are each selected from a substituted or unsubstituted carbon, wherein one of P1-P4 is optionally replaced by a nitrogen atom, or the ring bearing P1-P4 is a thiophene ring, wherein P3-P4 together are replaced by a sulfur atom;
Z1 is CH or a carbon substituted with R7;
Z2 is CH or a carbon substituted with R8;
Z3, Z4 and Z5 are each independently selected from CH or a carbon substituted with R9;
R7 is C1-3 alkoxy, C1-3 haloalkoxy, cyano, C1-3 cyanoalkyl, halo, C1-3 alkyl, or C1-3 haloalkyl;
R8 is halo, C1-3 alkyl, C1-3 haloalkyl, or R7 and R8 are taken together with their intervening atoms to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
each R9 is independently selected from halo, cyano, trialkylsiloxy, C1-6 alkyl, C1-6 haloalkyl, C1-6 alkoxy, C1-6 haloalkoxy, C1-6 alkenyl, C1-6 alkynyl, N(R10)2, (C1-6 alkyl)-N(R10)2, O(C1-6 alkyl)-N(R10)2, C1-6 alkylsulfonyl, C1-6 alkylthio, or phenyl, or two R9 on neighboring carbons are taken together to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen, or sulfur;
each R10 is independently selected from hydrogen, C1-4 alkyl, or two R10 on the same nitrogen are taken together with their intervening nitrogen to form a 5-6 membered ring having 1-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
L2 is a covalent bond, a substituted or unsubstituted 1-2 carbon chain or a 2 carbon carbonyl chain, wherein one of the carbons along with the hydrogen attached thereto is optionally replaced by oxygen, N(R10), or sulfur;
t is CH2, CHR3, or CR3R4, and s is CH2, CHR5, or CR5R6, or t-s taken together is CH═CH, CR3═CH, CH═CR5 or CR3═CR5;
R3, R4, R5, and R6 are each independently selected from C1-4 alkyl, C1-4 alkylcarboxyl, C1-4 alkoxycarbonyl, C1-4 alkylcarboxamide, or two of R3, R4, R5, and R6 are taken together with their intervening atom or atoms to form a fused 3-7 membered aromatic or non-aromatic or 3-7 membered spirocyclic ring, having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
R is hydrogen or a C1-8 alkyl or C1-8 alkylcarbonyl that is substituted with 0-2 R11, or R and R5 are taken together with their intervening atoms to form a fused pyrrolidino or piperidino ring, or R and L2 are taken together with their intervening atoms to form a fused five membered ring having 1-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
each R11 is independently selected from C1-3 alkyl, cyano, halo, haloalkyl, N(R10)2, (C═O)N(R10)2, OC(═O)N(R10)2, OH, S(C1-6 alkyl), SO2(C1-6 alkyl), SO2N(R10)2, C1-6 alkoxy, C1-6 alkylcarbonyl, C1-6 alkylcarboxyl, C1-6 alkoxycarboxyl, C5-6 aryl, C6-10 arylalkyl, or a 3-6 membered heterocyclyl having 1 or 2 heteroatoms.

### Claim 2 (depends on 1)

The compound of claim 1 wherein P1, P2, P3 and P4 are each selected from a substituted or unsubstituted carbon.

### Claim 3 (depends on 2)

The compound of claim 2 having one or more features selected from the group consisting of:
(a) Z1 is a carbon substituted with R7;
(b) Z2, Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2;
(f) s is CH2; and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11.

### Claim 4 (depends on 3)

The compound of claim 3 wherein:
(a) Z1 is a carbon substituted with R7;
(b) Z2, Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2;
(f) s is CH2; and
(g) R is hydrogen or C18 alkyl that is substituted with 0-2 R11.

### Claim 5 (depends on 3)

The compound of claim 3 having one or more features selected from the group consisting of:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 is alkoxy;
(c) R9 is halo, cyano or alkynyl; and
(d) R is hydrogen, or C1-4 alkyl that is substituted with 0-2 R11, wherein each R11 is independently selected from C1-3 alkyl, cyano, halo, C1-4 alkoxy, or a 5-6 membered heterocyclyl having 1 or 2 heteroatoms.

### Claim 6 (depends on 4)

The compound of claim 4 wherein:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 is alkoxy;
(c) R9 is halo, cyano or alkynyl; and
(d) R is hydrogen, or C1-4 alkyl that is substituted with 0-2 R11, and each R11 is independently selected from C1-3 alkyl, cyano, halo, C1-4 alkoxy, or a 5-6 membered heterocyclyl having 1 or 2 heteroatoms.

### Claim 7 (depends on 2)

The compound of claim 2 having one or more features selected from the group consisting of:
(a) Z1 is a carbon substituted with R7, Z2 is a carbon substituted with R8, and R7 and R8 are taken together to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
(b) Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2;
(f) s is CH2; and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11.

### Claim 8 (depends on 7)

The compound of claim 7 wherein:
(a) Z1 is a carbon substituted with R7, Z2 is a carbon substituted with R8, and R7 and R8 are taken together to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
(b) Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2;
(f) s is CH2; and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11.

### Claim 9 (depends on 7)

The compound of claim 7 having one or more features selected from the group consisting of:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 and R8 are taken together to form a substituted or unsubstituted benzo, furano, thieno, dioxolo ring.
(c) R9 is halo, cyano or alkynyl; and
(d) R is hydrogen, or C1-4 alkyl that is substituted with 0-2 R11, and each R11 is independently selected from C1-3 alkyl, cyano, halo, C1-4 alkoxy, or a 5-6 membered heterocyclyl having 1 or 2 heteroatoms.

### Claim 10 (depends on 8)

The compound of claim 8 wherein:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 and R8 are taken together to form a substituted or unsubstituted benzo, furano, thieno, dioxolo ring.
(c) R9 is halo, cyano or alkynyl; and
(d) R is hydrogen, or C1-4 alkyl that is substituted with 0-2 R11, and each R11 is independently selected from C1-3 alkyl, cyano, halo, C1-4 alkoxy, or a 5-6 membered heterocyclyl having 1 or 2 heteroatoms.

### Claim 11 (depends on 2)

The compound of claim 2 having one or more features selected from the group consisting of:
(a) Z1 is a carbon substituted with R7;
(b) Z2, Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2 or CHR3;
(f) s is CHR5, or CR5R6, and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11;
wherein R3 and R5 are optionally taken together with their intervening atom or atoms to form a fused 3-7 membered aromatic or non-aromatic ring or R and R5 are optionally taken together with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 12 (depends on 11)

The compound of claim 11 wherein:
(a) Z1 is a carbon substituted with R7;
(b) Z2, Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2 or CHR3;
(f) sis CHR5, or CR5R6,
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11,
wherein R3 and R5 are optionally taken together with their intervening atom or atoms to form a fused 3-7 membered aromatic or non-aromatic ring or R and R5 are optionally taken together with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 13 (depends on 11)

The compound of claim 11 having one or more features selected from the group consisting of:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 is alkoxy;
(c) R9 is halo, cyano or alkynyl; and
(d) s is CHR5, wherein R5 is taken together with R3 to form a fused 5-6 membered non-aromatic ring, or R5 is taken together with R with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 14 (depends on 12)

The compound of claim 12 wherein:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 is alkoxy;
(c) R9 is halo, cyano or alkynyl; and
(d) s is CHR5, wherein R5 is taken together with R3 to form a fused 5-6 membered non-aromatic ring, or R5 is taken together with R with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 15 (depends on 2)

The compound of claim 2 having one or more features selected from the group consisting of:
(a) Z1 is a carbon substituted with R7, Z2 is a carbon substituted with R8, and R7 and R8 are taken together to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
(b) Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2 or CHR3;
(f) s is CUR5, or CR5R6, wherein R3 and R5 are optionally taken together with their intervening atom or atoms to form a fused 3-7 membered aromatic or non-aromatic ring; and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11, or R and R5 are taken together with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 16 (depends on 15)

The compound of claim 15 wherein:
(a) Z1 is a carbon substituted with R7, Z2 is a carbon substituted with R8, and R7 and R8 are taken together to form a fused, 5-6 membered aromatic or nonaromatic ring having 0-2 ring heteroatoms selected from oxygen, nitrogen or sulfur;
(b) Z3 and Z5 are each CH;
(c) Z4 is a carbon substituted with R9;
(d) L2 is a covalent bond;
(e) t is CH2 or CHR3;
(f) s is CHR5, or CR5R6, wherein R3 and R5 are optionally taken together with their intervening atom or atoms to form a fused 3-7 membered aromatic or non-aromatic ring; and
(g) R is hydrogen or C1-8 alkyl that is substituted with 0-2 R11, or R and R5 are taken together with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 17 (depends on 15)

The compound of claim 15 having one or more features selected from the group consisting of:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 and R8 are taken together to form a substituted or unsubstituted benzo, furano, thieno, dioxolo ring.
(c) R9 is halo, cyano or alkynyl; and
(d) s is CHR5, wherein R5 is taken together with R3 to form a fused 5-6 membered non-aromatic ring, or R5 is taken together with R with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 18 (depends on 16)

The compound of claim 16 wherein:
(a) P1, P2, and P3 are each an unsubstituted carbon, and P4 is an unsubstituted carbon, or a carbon substituted with a halogen or alkoxy;
(b) R7 and R8 are taken together to form a substituted or unsubstituted benzo, furano, thieno, dioxolo ring.
(c) R9 is halo cyano or alkynyl; and
(d) s is CHR5, wherein R5 is taken together with R3 to form a fused 5-6 membered non-aromatic ring, or R5 is taken together with R with their intervening atoms to form a fused pyrrolidino or piperidino ring.

### Claim 19

A compound selected from the group consisting of:
819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865

### Claim 20 (depends on 1)

A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

### Claim 21 (depends on 1)

A method of treating an MC4-R associated disorder in a patient in need thereof comprising administering to said patient a compound of formula (XVII) in claim 1.

### Claim 22 (depends on 1)

A method of treating an MC4-R associated disorder in a patient in need thereof comprising administering to said patient a pharmaceutical composition comprising a compound of formula (XVII) in claim 1.

### Claim 23 (depends on 1)

A method of treating a weight loss disorder in a subject identified as in need of such treatment comprising administering a compound of formula (XVII) in claim 1.

### Claim 24 (depends on 23)

The method of claim 23, wherein the weight loss disorder is a cachexia, aging involuntary weight loss, sarcopenia, catabolic wasting, or anorexia.

### Claim 25 (depends on 24)

The method of claim 24, wherein cachexia is cancer cachexia, cardiac cachexia, chronic illness cachexia, or AIDS cachexia.

### Claim 26 (depends on 1)

A method of inhibiting MC4-R activity in a patient in need thereof comprising administering to said patient a pharmaceutical composition comprising a compound of formula (XVII) in claim 1.
